Robeco Institutional Asset Management B.V. Bristol Myers Squibb CO Transaction History
Robeco Institutional Asset Management B.V.
- $46 Billion
- Q2 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 4,300,568 shares of BMY stock, worth $209 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,300,568
Previous 3,106,837
38.42%
Holding current value
$209 Million
Previous $168 Million
6.01%
% of portfolio
0.39%
Previous 0.37%
Shares
40 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...